loading page

Anaphylaxis in children
  • Luciana Tanno,
  • Pascal Demoly
Luciana Tanno
Hospital Sírio-Libanês
Author Profile
Pascal Demoly
CHU Arnaud de Villeneuve
Author Profile


Anaphylaxis in children is a potential acute life-threatening systemic hypersensitivity reaction. Anaphylaxis fatality rate is estimated to be 0.65% to 2%. Food is the main anaphylaxis trigger in children, notably cow’s milk, peanuts and tree nuts. Mucocutaneous manifestations are observed in more than 90% of cases, but it is not essential for diagnosis. Deaths are rather secondary to the laryngeal edema, observed in 40-50% of cases. Personal history of asthma, allergy to particular foods such as peanuts and tree nuts, and adolescence are known risk factors for anaphylaxis and more severe reactions. Epinephrine (adrenaline) is the medication of choice for the first-aid treatment of anaphylaxis. However, adrenaline auto-injectors (AAIs) are commercially available in only 32% of world countries. There are still considerable unmet needs in the field of anaphylaxis in children. Therefore, the Montpellier WHO Collaborating Centre aims to start the global actions plan applied to anaphylaxis.

Peer review status:Published

29 Jun 2020Submitted to Pediatric Allergy and Immunology
30 Jun 2020Editorial Decision: Accept
Nov 2020Published in Pediatric Allergy and Immunology volume 31 issue S26 on pages 8-10. 10.1111/pai.13336